Correlation Between Enveric Biosciences and Capricor Therapeutics
Can any of the company-specific risk be diversified away by investing in both Enveric Biosciences and Capricor Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enveric Biosciences and Capricor Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enveric Biosciences and Capricor Therapeutics, you can compare the effects of market volatilities on Enveric Biosciences and Capricor Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enveric Biosciences with a short position of Capricor Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enveric Biosciences and Capricor Therapeutics.
Diversification Opportunities for Enveric Biosciences and Capricor Therapeutics
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Enveric and Capricor is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Enveric Biosciences and Capricor Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Capricor Therapeutics and Enveric Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enveric Biosciences are associated (or correlated) with Capricor Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Capricor Therapeutics has no effect on the direction of Enveric Biosciences i.e., Enveric Biosciences and Capricor Therapeutics go up and down completely randomly.
Pair Corralation between Enveric Biosciences and Capricor Therapeutics
Given the investment horizon of 90 days Enveric Biosciences is expected to under-perform the Capricor Therapeutics. In addition to that, Enveric Biosciences is 1.59 times more volatile than Capricor Therapeutics. It trades about -0.01 of its total potential returns per unit of risk. Capricor Therapeutics is currently generating about 0.07 per unit of volatility. If you would invest 422.00 in Capricor Therapeutics on October 22, 2024 and sell it today you would earn a total of 948.00 from holding Capricor Therapeutics or generate 224.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enveric Biosciences vs. Capricor Therapeutics
Performance |
| Timeline |
| Enveric Biosciences |
| Capricor Therapeutics |
Enveric Biosciences and Capricor Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enveric Biosciences and Capricor Therapeutics
The main advantage of trading using opposite Enveric Biosciences and Capricor Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enveric Biosciences position performs unexpectedly, Capricor Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capricor Therapeutics will offset losses from the drop in Capricor Therapeutics' long position.| Enveric Biosciences vs. Ocean Biomedical | Enveric Biosciences vs. Hepion Pharmaceuticals | Enveric Biosciences vs. Elevation Oncology | Enveric Biosciences vs. Zura Bio Limited |
| Capricor Therapeutics vs. Bio Path Holdings | Capricor Therapeutics vs. NextCure | Capricor Therapeutics vs. Pulmatrix | Capricor Therapeutics vs. Akari Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |